sw900 human lung squamous cell carcinoma lusc cell lines (ATCC)
Structured Review

Sw900 Human Lung Squamous Cell Carcinoma Lusc Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 141 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sw900 human lung squamous cell carcinoma lusc cell lines/product/ATCC
Average 95 stars, based on 141 article reviews
Images
1) Product Images from "Comprehensive multi omics profiling and Mendelian randomization assessment of lipid metabolites in lung cancer prognosis"
Article Title: Comprehensive multi omics profiling and Mendelian randomization assessment of lipid metabolites in lung cancer prognosis
Journal: Discover Oncology
doi: 10.1007/s12672-026-04893-6
Figure Legend Snippet: Mendelian Randomization Analysis Reveals Causal Relationship Between Phosphatidylcholine and Lung Cancer. A and B show meta-analysis forest plots demonstrating that phosphatidylcholine levels are significantly associated with LUSC risk across multiple studies. The red diamonds represent pooled effect estimates. C presents MR test scatter plots using three different methods (inverse variance weighted, MR-Egger, and weighted median). The consistent regression line slopes across methods indicate a robust causal effect estimate. D compares results from different MR methods, with the blue line showing the primary analysis and scattered points representing alternative approaches. The consistency across methods supports the reliability of findings
Techniques Used:
Figure Legend Snippet: Mendelian Randomization Analysis Reveals Associations between LUSC and Metabolites. The charts present Mendelian randomization findings exploring the link between lung cancer and metabolites. A and B illustrate the associations, while C and D confirm consistency. The analysis suggests significant relations between certain metabolites and lung cancer risk, offering new insights for research
Techniques Used:
Figure Legend Snippet: RT-qPCR Validation of Prognostic Genes. Relative mRNA expression of CD44, OR51E2, KRT5, and S100A9 in H520 and SW900 lung squamous cell carcinoma (LUSC) cell lines vs. BEAS-2B controls. *** P < 0.001, **** P < 0.0001
Techniques Used: Quantitative RT-PCR, Biomarker Discovery, Expressing